GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.6800
-0.0420 (-5.82%)
At close: Jan 29, 2026, 4:00 PM EST
0.7109
+0.0309 (4.54%)
After-hours: Jan 29, 2026, 7:32 PM EST
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $7.23 million as of January 29, 2026. Its market cap has increased by 29.15% in one year.
Market Cap
7.23M
Enterprise Value
4.70M
1-Year Change
29.15%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $7.23M, a decrease of -91.31%. That is a compound annual growth rate of -26.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 7.20M | -13.25% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuron | 7.96M |
| Kiora Pharmaceuticals | 7.96M |
| Alzamend Neuro | 7.83M |
| MetaVia | 7.56M |
| Calidi Biotherapeutics | 7.32M |
| Quoin Pharmaceuticals | 7.24M |
| Mustang Bio | 7.19M |
| Creative Medical Technology Holdings | 7.16M |